Skip to main content

Advertisement

Log in

Correlation of l-methyl-11C-methionine (MET) uptake with l-type amino acid transporter 1 in human gliomas

  • Clinical Study - Patient Study
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

l-Type amino acid transporter 1 (LAT1) is a neutral amino acid transport system and is a major route for the transport of large neutral amino acids, including methionine, through the plasma membrane. LAT1 requires the heavy chain of 4F2 cell surface antigen (4F2hc) for its functional expression. Positron emission tomography (PET) with l-[methyl-11C] methionine (MET) provides information about amino acid metabolism in brain tumors. We conducted a clinicopathologic study to elucidate the correlation of LAT1 and 4F2hc expression with MET uptake in patients with newly diagnosed human gliomas. Thirty-three newly diagnosed glioma patients were enrolled in this study. Uptake of MET in the tumor was evaluated with the maximum standardized uptake value (SUVmax). Expression of the LAT1, 4F2hc, and CD34, and Ki-67 labeling index of the tumor were analyzed by immunohistochemical staining, and the correlation with the SUVmax in the tumors was examined. Expression of LAT1 and 4F2hc was higher in high-grade gliomas than in low-grade gliomas. The grade of LAT1 immunostaining increased with glioma grade. LAT1 was mainly expressed in the tumor cytoplasm and vascular endothelium and 4F2hc was mainly expressed in the tumor cytoplasm and plasma membrane. Expression of LAT1 but not 4F2hc was significantly correlated with MET SUVmax. Expression of LAT1 in the tumor vascular endothelium is significantly correlated with CD34 positive microvessel density. In conclusion, MET SUVmax correlates with LAT1 expression in the tumor in newly diagnosed gliomas. MET transport may be increased by an increased number of microvessels combined with a higher density or activity of LAT1 in the tumor endothelial cells in high-grade gliomas. Use of MET-PET as a molecular target combined with anti-angiogenesis in glioma therapy should be addressed in future studies.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

References

  1. Borbély K, Nyáry I, Tóth M, Ericson K, Gulyás B (2006) Optimization of semi-quantification in metabolic PET studies with 18F-fluorodeoxyglucose and 11C-methionine in the determination of malignancy of gliomas. J Neurol Sci 246:85–94

    Article  PubMed  Google Scholar 

  2. Ceyssens S, Van Laere K, de Groot T, Goffin J, Bormans G, Mortelmans L (2006) [11C]methionine PET, histopathology, and survival in primary brain tumors and recurrence. AJNR Am J Neuroradiol 27:1432–1437

    CAS  PubMed  Google Scholar 

  3. Chung J-K, Lee YJ, Kim SK, Jeong JM, Lee DS, Lee MC (2004) Comparison of [18F]fluorodeoxyglucose uptake with glucose transporter-1 expression and proliferation rate in human glioma and non-small-cell lung cancer. Nucl Med Commun 25:11–17

    Article  CAS  PubMed  Google Scholar 

  4. Galldiks N, Kracht LW, Berthold F, Miletic H, Klein JC, Herholz K, Jacobs AH, Heiss W-D (2009) [11C]-l-methionine positron emission tomography in the management of children and young adults with brain tumors. J Neurooncol. doi: 10.1007/s11060-009-9953-x

  5. Hatakeyama T, Kawai N, Nishiyama Y, Yamamoto Y, Sasakawa Y, Ichikawa T, Tamiya T (2008) 11C-methionine (MET) and 18F-fluorothymidine (FLT) PET in patients with newly diagnosed glioma. Eur J Nucl Med Mol Imaging 35:2009–2017

    Article  CAS  PubMed  Google Scholar 

  6. Herholz K, Hölzer T, Bauer B, Schröder R, Voges J, Ernestus R-I, Mendoza G, Weber-Luxenburger G, Löttgen J, Thiel A, Wienhard K, Heiss W-D (1998) 11C-methionine PET for differential diagnosis of low-grade gliomas. Neurology 50:1316–1322

    CAS  PubMed  Google Scholar 

  7. Ishiwata K, Ido T, Vaalburg W (1988) Increased amounts of d-enantiomer dependent on alkaline concentration in the synthesis of l-[methyl-11C] methionine. Int J Rad Appl Instrum A 39:311–314

    Article  CAS  PubMed  Google Scholar 

  8. Ishiwata K, Kubota K, Murakami M, Kubota R, Sasaki T, Ishii S, Senda M (1993) Re-evaluation of amino acid PET studies: can the protein synthesis rates in brain and tumor tissue be measured in vivo? J Nucl Med 34:1936–1943

    CAS  PubMed  Google Scholar 

  9. Kanai Y, Segawa H, Miyamoto K, Uchino H, Takeda E, Endou H (1998) Expression cloning and characterization of a transporter for a large neutral amino acid activated by the heavy chain of 4F2 antigen (CD98). J Biol Chem 273:23629–23632

    Article  CAS  PubMed  Google Scholar 

  10. Kaschten B, Stevenaert A, Sadzot B, Deprez M, Degueldre C, Fiore GD, Luxen A, Reznik M (1998) Preoperative evaluation of 54 gliomas by PET with fluorine-18- fluorodeoxyglucose and/or carbon-11-methionine. J Nucl Med 39:778–785

    CAS  PubMed  Google Scholar 

  11. Kim S, Chung J-K, Im S-H, Jeong JM, Lee DS, Kim DG, Jung HW, Lee MC (2005) 11C-methionine PET as a prognostic marker in patients with glioma: comparison with 18F-FDG PET. Eur J Nucl Med Mol Imaging 32:52–59

    Article  CAS  PubMed  Google Scholar 

  12. Kleemola M, Toivonen M, Mykkänen J, Simell O, Huoponen K, Heiskanen KM (2007) Heterodimerization of y(+)LAT-1 and 4F2hc visualized by acceptor photobleaching FRET microscopy. Biochim Biophys Acta 1768:2345–2354

    Article  CAS  PubMed  Google Scholar 

  13. Kobayashi K, Ohnishi A, Promsuk J, Shimizu S, Kanai Y, Shiokawa Y, Nagane M (2007) Enhanced tumor growth elicited by l-type amino acid transporter 1 in human malignant glioma cells. Neurosurgery 62:493–504

    Article  Google Scholar 

  14. Kracht LW, Friese M, Herholz K, Schroeder R, Bauer B, Jacobs A, Heiss W-D (2003) Methyl-[11C]-l-methionine uptake as measured by positron emission tomography correlates to microvessel density in patients with glioma. Eur J Nucl Med Mol Imaging 30:868–873

    CAS  PubMed  Google Scholar 

  15. Lahoutte T, Caveliers V, Camargo SMR, Franca R, Pharm D, Ramadan T, Veljkovic E, Mertens J, Bossuyt A, Verrey F (2004) SPECT and PET amino acid tracer influx via system L (h4H2hc-hLAT1) and its transstimulation. J Nucl Med 45:1591–1596

    CAS  PubMed  Google Scholar 

  16. Matsuo H, Tsukada S, Nakata T, Chairoungdua A, Kim DK, Cha SH, Inatomi J, Yorifuji H, Fukuda J, Endou H, Kanai Y (2000) Expression of a system l neutral amino acid transporter at the blood–brain barrier. NeuroReport 11:3507–3511

    Article  CAS  PubMed  Google Scholar 

  17. Nariai T, Tanaka Y, Wakimoto H, Aoyagi M, Tamaki M, Ishikawa K, Senda M, Ishii K, Hirakawa K, Ohno K (2005) Usefulness of l-[methyl-11C] methionine-positron emission tomography as a biological monitoring tool in the treatment of glioma. J Neurosurg 103:498–507

    Article  PubMed  Google Scholar 

  18. Nawashiro H, Otani N, Uozumi Y, Ooigawa H, Toyooka T, Suzuki T, Katoh H, Tsuzuki N, Ohnuki A, Shima K, Shinomiya N, Matsuo H, Kanai Y (2005) High expression of l-type amino acid transporter 1 in infiltrating glioma cells. Brain Tumor Pathol 22:89–91

    Article  CAS  PubMed  Google Scholar 

  19. Nawashiro H, Otani N, Shinomiya N, Fukui S, Ooigawa H, Shima K, Matsuo H, Kanai Y, Endou H (2006) l-type amino acid transporter 1 as a potential molecular target in human astrocytic tumors. Int J Cancer 119:484–492

    Article  CAS  PubMed  Google Scholar 

  20. Norden AD, Drappatz J, Wen PY (2008) Novel anti-angiogenic therapies for malignant gliomas. Lancet Neurol 7:1152–1160

    Article  CAS  PubMed  Google Scholar 

  21. Stöber B, Tanase U, Herz M, Seidl C, Schwaiger M, Senekowitsch-Schmidetke P (2006) Differentiation of tumour and inflammation: characterization of [methyl-3H] methionine (MET) and Ο-(2-[18F]fluoroethyl-l-tyrosine (FET) uptake in human tumour and inflammatory cells. Eur J Nucl Med Mol Imaging 33:932–939

    Article  PubMed  Google Scholar 

  22. Stockhammer F, Plotkin M, Amthauer H, van Landeghem FKH, Woiciechowsky C (2008) Correlation of F-18-fluoro-ethyl-tyrosin uptake with vascular and cell density in non-contrast-enhancing gliomas. J Neurooncol 88:205–210

    Article  CAS  PubMed  Google Scholar 

  23. Tibbetts KM, Emnett RJ, Gao F, Perry A, Gutmann DH, Leonard JR (2009) Histopathologic predictors of pilocytic astrocytoma event-free survival. Acta Neuropathol 117:657–665

    Article  CAS  PubMed  Google Scholar 

  24. Weber WA, Dick S, Reidl G, Dzewas B, Busch R, Feldmann H-J, Molles M, Lumenta CB, Schwaiger M, Grosu AL (2001) Correlation between postoperative 3-[123I]iodo-l-α-methyltyrosine uptake and survival in patients with gliomas. J Nucl Med 42:1144–1150

    CAS  PubMed  Google Scholar 

  25. Zhen HN, Zhang X, Hu PZ, Yang TT, Fei Z, Zhang JN, Fu LA, He XS, Ma FC, Wang XL (2005) Survivin expression and its relation with proliferation, apoptosis, and angiogenesis in brain gliomas. Cancer 104:2775–2783

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgment

Shuichi Okubo and Hai-Ning Zhen contributed equally to this study. The authors appreciate the excellent technical support of the radiological technologist at our institution.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Nobuyuki Kawai.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Okubo, S., Zhen, HN., Kawai, N. et al. Correlation of l-methyl-11C-methionine (MET) uptake with l-type amino acid transporter 1 in human gliomas. J Neurooncol 99, 217–225 (2010). https://doi.org/10.1007/s11060-010-0117-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-010-0117-9

Keywords

Navigation